Company Filing History:
Years Active: 2015-2024
Title: Marta Cosenza: Innovator in Antibody Formulations
Introduction
Marta Cosenza is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of six patents to her name, her work has the potential to impact patient care and treatment methodologies.
Latest Patents
One of her latest patents focuses on Anti-BAFFR antibody formulations and methods of use thereof. These formulations are designed as either lyophilisate or liquid formulations. The lyophilisates can be reconstituted to create a solution with a high concentration of the antibody active ingredient, allowing for effective delivery to patients without high levels of antibody aggregation. The lyophilisate can be reconstituted with an aqueous reconstituent to yield an aqueous composition in which the antibody concentration is at least 50 mg/ml. Additionally, the lyophilisate or aqueous pharmaceutical composition may include various components such as sugars, buffering agents, surfactants, and free amino acids.
Career Highlights
Marta has worked with notable companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma AG. Her experience in these organizations has allowed her to refine her expertise in antibody development and formulation.
Collaborations
Throughout her career, Marta has collaborated with esteemed colleagues such as Christoph Heusser and